Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 4, 2010 1:54 PM 3 min read

ProAssurance In Line with Estimates - Analyst Blog

by Zacks Benzinga Contributor
Follow
PRA Logo
PRAProAssurance Corp
$24.45-0.20%
Overview

ProAssurance Corporation (PRA) reported its third-quarter operating earnings of $41.5 million or $1.30 came in line with the Zacks Consensus Estimate. However, this compares unfavorably with earnings of $52.2 million or $1.58 per share in the prior-year quarter.

Net income in the quarter was $51.1 million or $1.59 per share, compared with $55.2 million or $1.67 in the prior-year quarter. Operating income excludes the after-tax effects of net realized gains or losses and guaranty fund assessments or recoupments and debt retirement loss. During the reported quarter, the effect of adjustment to net income was 29 cents per share, compared with 9 cents in the year-ago quarter.

Total revenue of ProAssurance declined slightly by 0.8% year over year to $181.1 million, exceeding the Zacks Consensus Estimate of $165.0 million.

Gross written premiums for the quarter decreased 5.9% year over year to $159 million. ProAssurance's retention in its consolidated medical professional liability physician book was 90% in the reported quarter.

ProAssurance experienced $33.4 million of favorable net loss reserve development in the reported quarter, compared with $42.5 million a year ago.

Net investment income for the quarter dipped 7.8% year over year to $35.6 million. ProAssurance's net investment result for the reported quarter decreased, primarily due to lower reinvestment rates on its fixed income portfolioalong with reduction in equity earnings of unconsolidated subsidiaries during the quarter.

Financial Ratios

ProAssurance's net loss ratio for the reported quarter came in at 61.3%, compared with 52.7% in the prior-year quarter. Expense ratio during the quarter was 24.0%, up from 21.9% in the prior-year quarter. Combined ratio slightly improved to 85.3% from 74.6% in the prior-year quarter.

However, return on equity (ROE) plummeted to 11.3% from 13.9% in the prior-year quarter. Book value of ProAssurance increased to $58.90 per share as of September 30, 2010 compared with $52.59 as of December 31, 2009.

Acquisition Update

Recently in September, ProAssurance agreed to acquire American Physicians Service Group, Inc. (AMPH) in an all-cash transaction. The shareholders of American Physicians will receive $32.50 per share in cash and the transaction is expected to close in the fourth quarter of 2010.

ProAssurance will offer superior quality insurance protection for the policyholders of American Physicians.The company also believes that this will prove to be a strategic expansion that will help grow both the business and top line in 2011.

Share Repurchase Update

During the reported quarter, ProAssurance repurchased approximately 975,000 shares of its common stock for about $55.3 million. As of September 30, 2010, the company had approximately $11.2 million of shares remaining under the existing share repurchase authorization approved in September 2009.

There are inherent threats associated with the medical professional liability insurance sector as a whole, stemming from price competition, legislative reform, loss cost trends and regulatory challenges. However, we anticipate the results of ProAssurance to reflect benefits of acquisitions, geographic diversity and strong financial position.



PROASSURANCE CP (PRA
): Free Stock Analysis Report


Zacks Investment Research
Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
FinancialsProperty & Casualty Insurance
PRA Logo
PRAProAssurance Corp
$24.45-0.20%
Overview
Comments
Loading...